Novel use of zinc gluconate for treating hydradenitis...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/315 (2006.01) A61K 9/14 (2006.01) A61K 9/20 (2006.01) A61K 33/30 (2006.01) A61P 17/00 (2006.01)

Patent

CA 2604028

The invention concerns a novel therapeutic use of zinc gluconate. Zinc gluconate is used in an orally deliverable form, in accordance with a daily dose schedule between 45 and 125 mg, for treating hydradenitis suppurativa, or Verneuil's disease.

L'invention concerne une nouvelle utilisation du gluconate de zinc en thérapeutique. Le gluconate de zinc est utilisé sous une forme administrable par voie orale, suivant une posologie journalière comprise entre 45 et 125 mg, pour le traitement de l'hidradénite suppurée, ou maladie de Verneuil.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel use of zinc gluconate for treating hydradenitis... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel use of zinc gluconate for treating hydradenitis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel use of zinc gluconate for treating hydradenitis... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1779901

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.